SCHEMBL30193194

SCHEMBL30193194

CS(=O)(=O)c1ccc(CN)cc1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSIP1 O75475 1/20 0.40
▸ CCR2 P41597 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LOXL2 Q9Y4K0 4/20 0.39
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ CA5B Q9Y2D0 1/20 0.38
▸ GPR119 Q8TDV5 3/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ MAOA P21397 2/20 0.36
▸ LOX P28300 1/20 0.36
▸ CHRM4 P08173 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5273904 1.00 PSIP1 (0.40) PSIP1CCR2L3MBTL1LOXL2CA1
Hydrochloric Acid SCHEMBL5278745 0.98 CA1 (0.40) PSIP1CCR2L3MBTL1LOXL2CA1
SCHEMBL17315470 0.87 F2 (0.46) L3MBTL1CA1CA2CA12CA4
SCHEMBL29744376 0.83 CA2 (0.48) PSIP1LOXL2CA1CA2CA12
SCHEMBL13211316 0.83 GPR119 (0.42) CCR2L3MBTL1CA2GPR119KCNH2
SCHEMBL19941004 0.83 CA2 (0.48) PSIP1LOXL2CA1CA2CA12
Hydrochloric Acid SCHEMBL19859178 0.81 CA2 (0.50) PSIP1LOXL2CA1CA2CA12
SCHEMBL30457289 0.81 CCR2 (0.40) CCR2L3MBTL1GPR119KCNH2CHRM4
SCHEMBL1940032 0.81 CYP4F2 (0.44) CCR2CA1CA2CA12CA4
SCHEMBL1940002 0.81 CCR2 (0.40) CCR2L3MBTL1GPR119KCNH2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115776891-A STAT degradants and uses thereof 凯麦拉医疗公司 2023-03-10 — — CN disclosed
EP-4121055-A1 STAT DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 — — EP disclosed
Send feedback